| ANIXA BIOSCIENCES DL -,01 |
| USA |
| Gesundheit |
| US03528H1095 / A2N6ZF |
| CY71 (Frankfurt) / ANIX (NASDAQ) |
| FRA:CY71, ETR:CY71, CY71:GR, NASDAQ:ANIX |
| - |
| https://www.anixa.com/ |
|
Anixa Biosciences Inc. is a biotechnology company ..
>Volltext.. |
| 121.74 Mio. EUR |
| 106.79 Mio. EUR |
| - |
| -10.3 Mio. EUR |
| -9.58 Mio. EUR |
| -0.3 EUR |
| 0.18 Mio. EUR |
| 1.29 Mio. EUR |
| -5.9 Mio. EUR |
| 7.76 |
| - |
| 14.72% |
| - |
| - |
| - |
| - |
| ANIXA BIOSCIENCES, ANIXA BIOSCIENCE, ANIXA BIO |
| 21.10.25 |
|